Array-derived CHIP was not associated with OS in FinnGen participants without RA (HR, 0.99; 95% CI, 0.88 to 1.11; P = 0.812; Fig. 3D), suggesting that CHIP may decrease survival specifically in patients with RA. Here, STUB1 is linked to rheumatoid arthritis.